World Wires · story 23670 · unverified · 1 source(s)

Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update

Marvel Biosciences’ Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update

Open in the desk

Coverage

• Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update GlobeNewswire: public companies · tier D · clear net · 2026-10-06 10:45 UTC

What this site indexes